Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH
ReutersAug 15, 2025 9:33 PM
Aug 15 (Reuters) - Novo Nordisk NOVOb.CO said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition known as metabolic dysfunction-associated steatohepatitis.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Costco FY2025 Q4 Earnings Preview: Decoding Growth Drivers and Market Bets Amid Sky-High Valuation
TradingKey - Since the release of Costco's fiscal 2025 third-quarter earnings report, its stock performance has slightly underperformed the S&P 500 index. After a significant year-to-date rally, the stock has entered a consolidation phase, exhibiting a contracting triangle pattern, reflecting...TradingKey
4 hours ago
Zeta Global (ZETA): Solid Data Moat Can Drive Value Up
TradingKey - Simply speaking, Zeta is a marketing tech company that leverages its high-quality, proprietary data and AI tools to automate a wide range of marketing tasks, helping marketers and brands conduct campaigns on various channels. The company’s solid moat is based on its high-quality...TradingKey
4 hours ago
-8fe429c75f0a48aa94f43d6c5c639094.jpg)
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...TradingKey
5 hours ago
Uranium Energy Corp. (UEC) Earnings Preview: Is there any Uranium out there?
TradingKey - Uranium Energy Corp (UEC) will report fourth-quarter and full-year earnings on the 24th of September, before the opening bell. The company’s stock price has been performing very strongly, being up 61% on a year-to-date basis - a rally closely related to uranium as a commodity.TradingKey
7 hours ago
_croped_889x500 (1)-666c3deec8f74a1d91bccfc0edb42909.jpg)
AI’s Next Battlefield: Broadcom’s TPU-Backed ASICs Challenge Nvidia’s GPU Dominance
TradingKey - Broadcom (NASDAQ: AVGO) recently secured a landmark $10 billion deal with OpenAI to supply custom AI accelerators, solidifying its leadership in the booming AI semiconductor market. Alongside its longstanding Google TPU partnership, this positions Broadcom to capture significant growthTradingKey
8 hours ago
.jpg)
Tradingkey
